Kangkeer

Chongqing Kangkeer Pharmaceutical Co., Ltd. was founded in 1999. Initially named "Chongqing Lisite Pharmaceutical Co., Ltd.", it acquired "Chongqing Kangrewi Pharmaceutical Co., Ltd." in 2007 and subsequently changed its name to the current one (Chongqing Kangkeer Pharmaceutical Co., Ltd.). Its current address is No. 101 Jinyu Avenue, Jingkai Park, Northern New District, Chongqing. The company integrates scientific research, production, and sales, and is a comprehensive enterprise mainly producing tablets and capsules while also producing some active pharmaceutical ingredients. The company is located at No. 101 Jinyu Avenue, Northern New District, Chongqing, and currently has 156 employees with excellent overall qualifications, with senior technical titles accounting for 9% and various professional and technical personnel accounting for over 75%. The company covers an area of 25,000 square meters, with a building area of 7,736.42 square meters and a registered capital of 25 million yuan. The entire plant has passed the GMP certification organized by the State Food and Drug Administration.
The company's current product dosage forms are tablets, capsules, and granules, with tablet production capacity reaching 1 billion tablets, capsule production capacity reaching 500 million capsules, and granule production capacity of 500 tons. Currently, Kangkeer has 21 registration approvals for formulation products and 3 registration approvals for active pharmaceutical ingredient production, forming multiple product series including hypoglycemic, antihypertensive, lipid-lowering, respiratory system, antibiotic, anti-allergic, and hepatobiliary medications. The company currently has a total of 27 registered trademarks and has obtained a total of 17 national patents. The company's Glimepiride Tablets (Liyiping Tablets), a national Class II new drug with an 8-year protection period, is a key new product evaluated by five national ministries and commissions. This product is now sold in all provinces and cities in China except Taiwan Province, and its sales volume ranks among the top in similar products nationwide. Our company has developed and researched Kang'erbeining and Kang'ershuning orally disintegrating tablets, which are characterized by dissolving in the mouth, requiring no water, being fast and efficient, and having a sweet taste. Chongqing Kangkeer is the first pharmaceutical company in China to obtain production registration approvals for this series, ranking 122nd among the 500 new products nationwide selected by authoritative departments in 2004, and 10th among new drugs.
Various honors the company has received in recent years:
November 2010, "Huangtengsu Capsules" was recognized as a Chongqing Municipal Scientific and Technological Achievement by the Chongqing Scientific and Technological Achievement Transformation Promotion Association;
November 2010, "Ambroxol Hydrochloride Orally Disintegrating Tablets and Preparation Method" was recognized as a Chongqing Municipal Scientific and Technological Achievement by the Chongqing Scientific and Technological Achievement Transformation Promotion Association;
July 2011, the company was awarded the title of "Chongqing Innovative Pilot Enterprise";
2011, the company was recognized as a "Leading Enterprise of the National Biological Industry Base";
June 2011, the company was awarded "Chongqing Key Supported Small and Medium-sized Enterprise";
May 2012, the "Liyiping" trademark was recognized as a Chongqing Famous Trademark by the Chongqing Administration for Industry and Commerce;
May 2012, "Metformin Hydrochloride Sustained-release Tablets" was rated as a "National Key New Product";
June 2012, "Glimepiride Tablets (1mg)" was rated as a "Chongqing High-tech Product";
June 2012, "Huangtengsu Capsules" was rated as a "Chongqing High-tech Product";
June 2012, "Telmisartan Tablets" was rated as a "Chongqing High-tech Product";
June 2012, "Metformin Hydrochloride Sustained-release Tablets" was rated as a "Chongqing High-tech Product";
June 2012, "Telmisartan Tablets" was rated as a "Chongqing Key New Product";
September 2012, rated by the Northern New District as a "2011 Contract-honoring and Credit-worthy Unit";
October 2012, the company was awarded the title of "Top 100 Small and Medium-sized Enterprises in Chongqing (First Session)".
August 2013, the company obtained the "High-tech Enterprise" certificate;

: